BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2025 9:22:03 AM | Browse: 120 | Download: 208
 |
Received |
|
2025-04-02 10:41 |
|
Peer-Review Started |
|
2025-04-02 10:41 |
|
First Decision by Editorial Office Director |
|
2025-05-09 13:18 |
|
Return for Revision |
|
2025-05-09 13:18 |
|
Revised |
|
2025-05-17 19:38 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-07-24 02:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-24 10:22 |
|
Articles in Press |
|
2025-07-24 10:22 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-03 08:14 |
|
Publish the Manuscript Online |
|
2025-09-25 09:22 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Field of Vision |
| Article Title |
Real-life practice of Kelleni’s protocol in treatment and post exposure prophylaxis of SARS-CoV-2 HV.1 and JN.1 subvariants
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mina Thabet Kelleni |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mina Thabet Kelleni, Assistant Professor, MD, PhD, Department of Pharmacology, College of Medicine, Minia University, Main Road Shalaby Land, Minya 61519, Egypt. mina.kelleni@mu.edu.eg |
| Key Words |
Severe acute respiratory syndrome coronavirus 2; HV.1; JN.1; Post exposure prophylaxis; Kelleni’s protocol; Nitazoxanide; Non-steroidal anti-inflammatory drugs |
| Core Tip |
Coronavirus disease 2019 (COVID-19) has claimed the lives of over seven million people worldwide. Most deaths have occurred among high-risk patients, making it crucial to find a protocol that is effective for post-exposure prophylaxis in this pandemic and future ones. This article provides insight into how Kelleni’s protocol was successfully and safely used to save lives among high-risk groups of COVID-19 patients amidst the ongoing evolution of severe acute respiratory syndrome coronavirus 2. |
| Publish Date |
2025-09-25 09:22 |
| Citation |
Kelleni MT. Real-life practice of Kelleni’s protocol in treatment and post exposure prophylaxis of SARS-CoV-2 HV.1 and JN.1 subvariants. World J Virol 2025; 14(3): 107903 |
| URL |
https://www.wjgnet.com/2220-3249/full/v14/i3/107903.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v14.i3.107903 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
